The Chemours Company
Stock Forecast, Prediction & Price Target
The Chemours Company Financial Estimates
The Chemours Company Revenue Estimates
The Chemours Company EBITDA Estimates
The Chemours Company Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $6.34B N/A | $6.79B 7.07% | $6.02B -11.28% | Avg: $6.18B Low: $6.04B High: $6.29B avg. 2.54% | Avg: $6.38B Low: $6.16B High: $6.55B avg. 3.35% | ||
Net Income
% change YoY
| $608M N/A | $578M -4.93% | $-238M -141.17% | Avg: $531M Low: $493.76M High: $534.01M avg. 323.10% | Avg: $787M Low: $731.39M High: $791.01M avg. 48.21% | ||
EBITDA
% change YoY
| $1.20B N/A | $1.20B -0.08% | $197M -83.63% | Avg: $812.97M Low: $795.53M High: $827.72M avg. 312.67% | Avg: $840.27M Low: $811.55M High: $861.90M avg. 3.35% | ||
EPS
% change YoY
| $3.69 N/A | $3.72 0.81% | -$1.6 -143.01% | Avg: $3.47 Low: $3.32 High: $3.59 avg. 316.87% | Avg: $5.14 Low: $4.91 High: $5.31 avg. 48.12% | ||
Operating Expenses
% change YoY
| $699M N/A | $828M 18.45% | $1.39B 68.84% | Avg: $762.75M Low: $746.39M High: $776.60M avg. -45.43% | Avg: $788.37M Low: $761.43M High: $808.67M avg. 3.35% | ||
FAQ
What is The Chemours Company stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 185.66% in 2025-2026.
We have gathered data from 5 analysts. Their low estimate is 493.76M, average is 531M and high is 534.01M.
What is The Chemours Company stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2.95% in 2025-2026.
We have gathered data from 6 analysts. Their low revenue estimate is $6.04B, average is $6.18B and high is $6.29B.
What is The Chemours Company stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 182.50% in 2025-2026.
We have gathered data from 5 analysts. Their low earnings per share estimate is $3.32, average is $3.47 and high is $3.58.
What is the best performing analyst?
In the last twelve months analysts have been covering The Chemours Company stock. The most successful analyst is Arun Viswanathan whose win rate is 33.33%. He has correctly predicted 1/3 price targets.